Skip to main content
Erschienen in: Cancer Causes & Control 1/2016

01.01.2016 | Original paper

Obesity, ethnicity, and quality of life among breast cancer survivors and women without breast cancer: the long-term quality of life follow-up study

Erschienen in: Cancer Causes & Control | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of this study was to examine the relationship between obesity and quality of life (QOL) among Hispanic and non-Hispanic white breast cancer survivors and population-based controls from the ‘Long-Term Quality of Life Study’—a 12- to 15-year follow-up study of breast cancer cases/survivors and controls from New Mexico (n = 451).

Methods

Using multiple linear regressions, obesity measures [body mass index (BMI) ≥ 30 kg/m2] at baseline and follow-up interview were modeled with composite scores for physical and mental health from the SF-36 Quality of Life Survey. Interaction between ethnicity and BMI and change in BMI were evaluated. All models were adjusted for age, ethnicity, Charlson Index, depression, fatigue, and physical activity.

Results

Baseline obesity (β = −6.58, p = 0.04) was significantly associated with decreased mental health among survivors, but not among controls. Obesity at baseline and follow-up were significantly associated with decreased physical health among survivors (baseline β = −10.51, p = 0.004; follow-up β = −7.16, p = 0.02) and controls (baseline β = −11.07, p < 0.001; follow-up β = −5.18, p = 0.04). No significant interactions between ethnicity and BMI were observed.

Conclusions

Our findings provide unique information about a diverse population of breast cancer survivors and controls and the impact of obesity on the mental and physical aspects of QOL.
Literatur
1.
Zurück zum Zitat DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252–271. doi:10.3322/caac.21235 CrossRefPubMed DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A (2014) Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 64(4):252–271. doi:10.​3322/​caac.​21235 CrossRefPubMed
2.
Zurück zum Zitat Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, Miller PE, Demark-Wahnefried W (2009) Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer 115(17):4001–4009. doi:10.1002/cncr.24436 CrossRefPubMedPubMedCentral Mosher CE, Sloane R, Morey MC, Snyder DC, Cohen HJ, Miller PE, Demark-Wahnefried W (2009) Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors. Cancer 115(17):4001–4009. doi:10.​1002/​cncr.​24436 CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56CrossRefPubMed Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163(1):49–56CrossRefPubMed
5.
Zurück zum Zitat Huerta EE (2003) Cancer statistics for Hispanics, 2003: good news, bad news, and the need for a health system paradigm change. CA Cancer J Clin 53(4):205–207CrossRefPubMed Huerta EE (2003) Cancer statistics for Hispanics, 2003: good news, bad news, and the need for a health system paradigm change. CA Cancer J Clin 53(4):205–207CrossRefPubMed
6.
Zurück zum Zitat Napoles-Springer AM, Ortiz C, O’Brien H, Diaz-Mendez M, Perez-Stable EJ (2007) Use of cancer support groups among Latina breast cancer survivors. J Cancer Surviv Res Pract 1(3):193–204. doi:10.1007/s11764-007-0029-7 CrossRef Napoles-Springer AM, Ortiz C, O’Brien H, Diaz-Mendez M, Perez-Stable EJ (2007) Use of cancer support groups among Latina breast cancer survivors. J Cancer Surviv Res Pract 1(3):193–204. doi:10.​1007/​s11764-007-0029-7 CrossRef
8.
9.
11.
Zurück zum Zitat Carver CS, Smith RG, Petronis VM, Antoni MH (2006) Quality of life among long-term survivors of breast cancer: different types of antecedents predict different classes of outcomes. Psycho-oncology 15(9):749–758. doi:10.1002/pon.1006 CrossRefPubMed Carver CS, Smith RG, Petronis VM, Antoni MH (2006) Quality of life among long-term survivors of breast cancer: different types of antecedents predict different classes of outcomes. Psycho-oncology 15(9):749–758. doi:10.​1002/​pon.​1006 CrossRefPubMed
12.
Zurück zum Zitat Mehnert A, Koch U (2008) Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res 64(4):383–391. doi:10.1016/j.jpsychores.2007.12.005 CrossRefPubMed Mehnert A, Koch U (2008) Psychological comorbidity and health-related quality of life and its association with awareness, utilization, and need for psychosocial support in a cancer register-based sample of long-term breast cancer survivors. J Psychosom Res 64(4):383–391. doi:10.​1016/​j.​jpsychores.​2007.​12.​005 CrossRefPubMed
14.
Zurück zum Zitat Paskett E, Herndon J II, Donohue K, Naughton M, Grubbs S, Pavy M, Hensley M, Stark N, Kornblith A, Bittoni M, for C, Leukemia Group B (2009) Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541. Cancer 115(5):1109–1120. doi:10.1002/cncr.24140 Paskett E, Herndon J II, Donohue K, Naughton M, Grubbs S, Pavy M, Hensley M, Stark N, Kornblith A, Bittoni M, for C, Leukemia Group B (2009) Health-related quality of life in long-term breast cancer survivors: differences by adjuvant chemotherapy dose in Cancer and Leukemia Group B study 8541. Cancer 115(5):1109–1120. doi:10.​1002/​cncr.​24140
18.
Zurück zum Zitat Maskarinec G, Murphy S, Shumay DM, Kakai H (2001) Dietary changes among cancer survivors. Eur J Cancer Care 10(1):12–20CrossRef Maskarinec G, Murphy S, Shumay DM, Kakai H (2001) Dietary changes among cancer survivors. Eur J Cancer Care 10(1):12–20CrossRef
19.
20.
Zurück zum Zitat Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP (2012) Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors. Cancer 118(16):4024–4031. doi:10.1002/cncr.27389 CrossRefPubMedPubMedCentral Paxton RJ, Phillips KL, Jones LA, Chang S, Taylor WC, Courneya KS, Pierce JP (2012) Associations among physical activity, body mass index, and health-related quality of life by race/ethnicity in a diverse sample of breast cancer survivors. Cancer 118(16):4024–4031. doi:10.​1002/​cncr.​27389 CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Smith AW, Alfano CM, Reeve BB, Irwin ML, Bernstein L, Baumgartner K, Bowen D, McTiernan A, Ballard-Barbash R (2009) Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomark Prev 18(2):656–663. doi:10.1158/1055-9965.EPI-08-0352 CrossRef Smith AW, Alfano CM, Reeve BB, Irwin ML, Bernstein L, Baumgartner K, Bowen D, McTiernan A, Ballard-Barbash R (2009) Race/ethnicity, physical activity, and quality of life in breast cancer survivors. Cancer Epidemiol Biomark Prev 18(2):656–663. doi:10.​1158/​1055-9965.​EPI-08-0352 CrossRef
22.
Zurück zum Zitat Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, Samet JM (1998) Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women’s Health Study. Am J Epidemiol 148(7):683–692CrossRefPubMed Gilliland FD, Hunt WC, Baumgartner KB, Crumley D, Nicholson CS, Fetherolf J, Samet JM (1998) Reproductive risk factors for breast cancer in Hispanic and non-Hispanic white women: the New Mexico Women’s Health Study. Am J Epidemiol 148(7):683–692CrossRefPubMed
24.
Zurück zum Zitat Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM (2001) Physical activity and breast cancer risk in hispanic and non-hispanic white women. Am J Epidemiol 154(5):442–450CrossRefPubMed Gilliland FD, Li YF, Baumgartner K, Crumley D, Samet JM (2001) Physical activity and breast cancer risk in hispanic and non-hispanic white women. Am J Epidemiol 154(5):442–450CrossRefPubMed
25.
Zurück zum Zitat Baumgartner KB, Annegers JF, McPherson RS, Frankowski RF, Gilliland FD, Samet JM (2002) Is alcohol intake associated with breast cancer in Hispanic women? The New Mexico Women’s Health Study. Ethn Dis 12(4):460–469PubMed Baumgartner KB, Annegers JF, McPherson RS, Frankowski RF, Gilliland FD, Samet JM (2002) Is alcohol intake associated with breast cancer in Hispanic women? The New Mexico Women’s Health Study. Ethn Dis 12(4):460–469PubMed
26.
Zurück zum Zitat Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee (1995). World Health Organ Tech Rep Ser 854:1–452 Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee (1995). World Health Organ Tech Rep Ser 854:1–452
27.
Zurück zum Zitat Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504CrossRefPubMed Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emplaincourt PO, Jacobs DR Jr, Leon AS (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32(9 Suppl):S498–S504CrossRefPubMed
28.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383CrossRefPubMed
29.
Zurück zum Zitat Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-Item Health Survey 1.0. Health Econ 2(3):217–227CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM (1993) The RAND 36-Item Health Survey 1.0. Health Econ 2(3):217–227CrossRefPubMed
30.
Zurück zum Zitat Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B (1995) Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 87(18):1372–1382CrossRefPubMed Ganz PA, Day R, Ware JE Jr, Redmond C, Fisher B (1995) Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 87(18):1372–1382CrossRefPubMed
31.
Zurück zum Zitat Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA (2003) Health-related quality-of-life measurement in randomized clinical trials in breast cancer–taking stock. J Natl Cancer Inst 95(4):263–281CrossRefPubMed Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA (2003) Health-related quality-of-life measurement in randomized clinical trials in breast cancer–taking stock. J Natl Cancer Inst 95(4):263–281CrossRefPubMed
32.
Zurück zum Zitat Hosmer D, Lemeshow S (1989) Applied logistic regression. Wiley, New York Hosmer D, Lemeshow S (1989) Applied logistic regression. Wiley, New York
34.
Zurück zum Zitat Sirtori A, Brunani A, Villa V, Berselli ME, Croci M, Leonardi M, Raggi A (2012) Obesity is a marker of reduction in QoL and disability. Sci World J 2012:167520. doi:10.1100/2012/167520 CrossRef Sirtori A, Brunani A, Villa V, Berselli ME, Croci M, Leonardi M, Raggi A (2012) Obesity is a marker of reduction in QoL and disability. Sci World J 2012:167520. doi:10.​1100/​2012/​167520 CrossRef
35.
Zurück zum Zitat Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, Baumgartner KB, Bernstein L, Wang CY, Duggan C, Ballard-Barbash R, McTiernan A (2013) Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 140(1):159–176. doi:10.1007/s10549-013-2594-y CrossRefPubMedPubMedCentral Imayama I, Alfano CM, Neuhouser ML, George SM, Wilder Smith A, Baumgartner RN, Baumgartner KB, Bernstein L, Wang CY, Duggan C, Ballard-Barbash R, McTiernan A (2013) Weight, inflammation, cancer-related symptoms and health related quality of life among breast cancer survivors. Breast Cancer Res Treat 140(1):159–176. doi:10.​1007/​s10549-013-2594-y CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Luckett T, Goldstein D, Butow PN, Gebski V, Aldridge LJ, McGrane J, Ng W, King MT (2011) Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. Lancet Oncol 12(13):1240–1248. doi:10.1016/S1470-2045(11)70212-1 CrossRefPubMed Luckett T, Goldstein D, Butow PN, Gebski V, Aldridge LJ, McGrane J, Ng W, King MT (2011) Psychological morbidity and quality of life of ethnic minority patients with cancer: a systematic review and meta-analysis. Lancet Oncol 12(13):1240–1248. doi:10.​1016/​S1470-2045(11)70212-1 CrossRefPubMed
Metadaten
Titel
Obesity, ethnicity, and quality of life among breast cancer survivors and women without breast cancer: the long-term quality of life follow-up study
Publikationsdatum
01.01.2016
Erschienen in
Cancer Causes & Control / Ausgabe 1/2016
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-015-0688-z

Weitere Artikel der Ausgabe 1/2016

Cancer Causes & Control 1/2016 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.